Alertas Bibliograficas – Diabetes
Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings. Shaw JL, Bannuru RR, Beach L et al.Diabetes Care. 2024. https://doi.org/10.2337/dci24-0073
De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial (TRANSITION‐T2D). Rodriguez P, Breslaw N, Xiao H et...
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Tacke F, Horn P, Wai-Sun Wong V et al.J Hepatol. 2024 Sep;81(3):492-542.https://doi.org/10.1016/j.jhep.2024.04.031
High frequency of severe hyperglycemia observed during intensive hematological care: a prospective study using continuous glucose monitoring.Tienstra M, de Boer JW, van Doesum JA et al.Endocr Pract. 2024. https://doi.org/10.1016/j.eprac.2024.09.013
Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis.Lewis SJ, Williams CL, Mortimer GL et al. Diabet Med. 2024. https://doi.org/doi:10.1111/dme.15394
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity. Drucker DJ.Diabetes Care. 2024 Jun 6:dci240003.doi:10.2337/dci24-0003
Understanding the cause of type 2 diabetes. Taylor R.Lancet Diabetes And Endocrinol. 2024.doi:10.1016/s2213-8587(24)00157-8
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetesAbdul-Ghani M, Maffei P, DeFronzo RA.Lancet Diabetes Endocrinol. 2024 Aug 1:S2213-8587(24)00127-X. doi: 10.1016/S2213-8587(24)00127-X
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Phillip M, Achenbach P, Addala A et al.Diabetes. Diabetes Care. 2024. doi:10.2337/dci24-004
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatmentRichard I G Holt, Clive S Cockram, Ronald C W Ma , Andrea O Y LukDiabetologia. 2024 Jul;67(7):1168-1180.doi: 10.1007/s00125-024-06102-x